News
📈 Stocks
Halozyme Shares Rally 59% YTD on Record $481M Q2 Revenue and Raised Guidance
(10 days ago)
Halozyme shares climb 59% this year as record-breaking Q2 earnings and aggressive institutional accumulation underscore the company's robust fundamental growth trajectory.